Lancet MMR autism fraud

From WikiMD's WELLNESSPEDIA

Lancet MMR Autism Fraud refers to a significant controversy that arose in the medical community following the publication of a research paper in 1998 by Andrew Wakefield, a British former gastroenterologist. The paper, published in the prestigious medical journal The Lancet, suggested a link between the Measles, Mumps, and Rubella (MMR) vaccine and the development of autism and bowel disease in children.

Background[edit]

Andrew Wakefield and his colleagues at the Royal Free Hospital in London published a case series study in The Lancet in February 1998. The study involved 12 children who had developed behavioral problems and bowel symptoms, and the paper suggested a new syndrome called autistic enterocolitis that linked the MMR vaccine to autism.

Controversy[edit]

The publication of the paper sparked a major health scare and led to a significant drop in vaccination rates in the UK and other parts of the world. However, numerous subsequent studies failed to reproduce Wakefield's findings, and a 2004 investigation by Sunday Times journalist Brian Deer revealed undisclosed financial conflicts of interest on Wakefield's part.

Retraction and aftermath[edit]

In 2010, following a lengthy investigation, the General Medical Council (GMC) found Wakefield guilty of serious professional misconduct. The Lancet fully retracted the paper, and Wakefield was struck off the UK medical register. Despite this, the controversy continues to have a lasting impact, contributing to ongoing debates about vaccine safety and the rise of vaccine hesitancy.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.